This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Peri-implantitis Treatment Market

Market Insights on Peri-implantitis Treatment covering sales outlook, demand forecast & up-to-date key trends

Peri-Implantitis Treatment Market by Method Type, End-User & Region - Forecast 2022 – 2032

Peri-Implantitis Treatment Market Snapshot (2022-2032)

[343 Pages Report] The global peri-implantitis treatment market is anticipated to be valued at US$ 2.3 Billion in 2022, forecast to grow at a CAGR of 8.7% to be valued at US$ 4.5 Billion from 2022 to 2032. Growth is attributed to rising usage of dental implants for prosthetic rehabilitation. From 2021 to 2022, a Y-o-Y growth rate of 4.5% is expected for the market, inclining from its previous valuation of US$ 2.2 Billion in 2021.

Report Attribute

Details

Estimated Base Year Value (2021)

US$ 2.2 Billion

Expected Market Value (2022)

US$ 2.3 Billion

Anticipated Forecast Value (2032)

US$ 4.5 Billion

Projected Growth Rate (2022-2032)

8.7% CAGR

Dental implants has turned to an established therapy in dentistry essential to replace missing teeth in different clinical situations. Peri-implantitis is a site-specific infectious disease,that affects the soft and hard tissue surrounding a dental implant. Peri-Implantitis is an inflammatory reaction with loss of a supporting bone in the tissues surrounding a dental implant.

According to the National Center for Biotechnology Information (NCBI), over an average follow-up of 2 years in the US, the prevalence of peri-implantitis was 34.0% on the patient level and 21% on the implant level. The rising demand for dental implants is a major factor that contributes to the growth of the market for peri-implantitis. However, the lack of awareness regarding the treatment is a major factor that hampers the market growth during the forecast period.  People having a history of periodontal disease are more susceptible to peri-implantitis.

According to the Centers for Disease Control and Prevention (CDC), in 2019, 47.2% of adults aged 30 years in the US had some form of periodontal disease, with the condition being more common in men than women, as they are more prone to smoking and health conditions like diabetes.

Customize this Report

Let us know your requirement to get
100% FREE customization

Which are Some Prominent Drivers Spearheading Peri-implantitis Treatment Market Growth?

The rising usage of dental implants for prosthetic rehabilitation is one of the major factors that is expected to accelerate the global peri-implantitis market during the forecast period. Growing public knowledge about oral hygiene has resulted in an increase in dental visits, which in turn is likely to boost the demand for peri-implantitis treatment market.

Moreover, the aging population is likely to play a significant role in fueling up the demand for peri-implantitis treatment over the analysis period. Technological advancements have resulted in several dental methods such as dental grafting, which are expected to present lucrative opportunities for market players in the peri-implantitis market.

Increased tobacco use and smoking rates cause a variety of oral disorders, which are expected to further increase the growth for peri-implantitis treatment during the forecast period.

Additionally, the rising demand for anti-aging treatments and procedures such as wrinkles, age spots, and other procedures is expected to propel the market growth during the forecast period, owing to the growing elderly population. Furthermore, advanced microdermabrasion devices are likely to expand in popularity among consumers, which would boost market expansion over the analysis period.

What are the Challenges Faced by the Peri-implantitis Treatment Industry?

The high cost of dental implants is one of the major factors that is expected to impede the growth of peri-implantitis treatment market during the forecast period. In addition, lack of skilled dental specialties can restrain the peri-implantitis treatment market.

In addition, the other major setback for the market’s growth is that the bone loss is only apparent in radiographs when 30% of the bone mass is lost, which can make early detection difficult. This in turn is expected to restrain the market growth.

Moreover, lack of awareness regarding the treatment is a major factor that hampers the peri-implantitis market in developing countries.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Why is North America Emerging as an Opportunistic Peri-implantitis Treatment Market?

The peri-implantitis market in North America is expected to hold largest share of US$ 719 Million, attributed to the availability of high healthcare expenditure. The regional market is expected to reach at a CAGR of 8.3% during the forecast period.

Factors such as the growing burden of dental diseases, and well-developed healthcare facilities in the region are also expected to augment the market’s growth over the analysis period.

Additionally, the market in the region is expected to propel, owing to the rise in geriatric population, increasing initiatives by the market players for technological advancements in peri-implantitis devices and highly aware population in the region.

How is Asia-Pacific Contributing to Growth of the Peri-implantitis Treatment Market?

The Asia-Pacific is expected to register the fastest growth in revenue generation for peri-implantitis treatment market due to the large population in countries such as China, and India.

On the other hand, factors such as the rising number of market players focusing on the launch of dental equipment in the region is expected to accelerate the market growth.

Availability of developed health care facilities and favorable government initiatives in India, China and Japan are the other major factors that will boost the market growth in the Asia-Pacific region, over the forecast period.

Populous countries like India and China suffer from a heavy burden of oral diseases and Dental Implants (DIs) are prescribed widely by dental practitioners to replace lost natural teeth and are gaining prominence. Moreover, India and China are currently the largest tobacco-producing and consuming countries having the lowest smoking awareness. These are the factors that are expected to fuel the market for peri-implantitis in the region. The Asia-Pacific peri-implantitis market is expected to reach at a CAGR of 8.1%.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Market Competition

Some of the key participants present in the global Peri-implantitis Treatment market include Pfizer Inc., Cadila Pharmaceuticals, and R.N. Laboratories Pvt. Ltd., Basic Pharma Life Science Pvt. Ltd., Prachi Pharmaceuticals Private Limited., Healthy Life Pharma Private Limited, Triveni chemicals, Geistlich Pharma, and Dawood & Tanner, among others.

Attributed to the presence of such high number of participants, the market is highly competitive. While global players such as Pfizer Inc., Cadila Pharmaceuticals, and R.N. Laboratories Pvt. Ltd. account for a considerable market size, several regional level players are also operating across key growth regions, particularly in the Asia Pacific.

Recent Developments:

  • In November 2020, Aspen Dental Management (ADMI) announced that it had signed an agreement with Sun Capital Partners, Inc. to acquire ClearChoice Management Services (CCMS), which provides comprehensive practice support services to the nationwide network of ClearChoice Dental Implant Centers.
  • In January 2019, OraCare announced the launch of implant post-op care system. The new system is designed to prevent development of peri-implantitis by targeting the specific microorganisms and compounds known to cause the complication.

Report Scope

Report Attribute

Details

Growth Rate

CAGR of 7% from 2022 to 2032

Market Value in 2022

US$ 2.3 Billion

Market Value in 2032

US$ 4.5 Billion

Base Year for Estimation

2021

Historical Data

2017-2021

Forecast Period

2022-2032

Quantitative Units

Revenue in USD Billion, Volume in Kilotons and CAGR from 2022-2032

Report Coverage

Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis

Segments Covered

  • Method Type
  • End-User
  • Region

Regional Scope

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Country Scope

  • U.S
  • Canada
  • Mexico
  • Brazil
  • Germany,
  • U.K
  • France
  • Spain
  • Italy
  • China
  • Japan
  • South Korea
  • Malaysia
  • Singapore
  • Australia
  • GCC
  • South Africa
  • Israel

Key Companies Profiled

Pricing and Purchase Options

Avail customized purchase options to meet your exact research needs.

Key Segments Profiled in the Peri-implantitis Treatment Industry Survey

Peri-Implantitis Treatment Market by Method Type:

  • Surgical Treatment of Peri-Implantitis
    • Mechanical Debridement
    • Laser Debridement
    • Open Flap Debridement
    • Open Flap Debridement with Guided Bone Generation
  • Non-Surgical Treatment of Peri-Implantitis
    • Surface Debridement
    • Antibiotics (Chlorhexidine Digluconate)
    • Others

Peri-Implantitis Treatment Market by End-User:

  • Peri-Implantitis Treatment in Hospitals
  • Peri-Implantitis Treatment in Dental Clinics

Peri-implantitis Treatment Market by Region:

  • North America Peri-Implantitis Treatment Market
  • Latin America Peri-Implantitis Treatment Market
  • Europe Peri-Implantitis Treatment Market
  • Asia Pacific Peri-Implantitis Treatment Market
  • Middle East & Africa Peri-Implantitis Treatment Market

Frequently Asked Questions

FMI projects the global Peri-implantitis Treatment market to expand at a 7% value CAGR by 2032

Asia Pacific is expected to be the most opportunistic Peri-implantitis Treatment market, expanding at 8.1% CAGR

Pfizer Inc., Cadila Pharmaceuticals, and R.N. Laboratories Pvt. Ltd., and Basic Pharma Life Science Pvt. Ltd. are some prominent Peri-implantitis Treatment manufacturers

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity 

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Peri-implantitis Treatment Market Analysis 2017-2021 and Forecast, 2022-2032

    4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021

    4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Peri-implantitis Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Method Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Mn) Analysis By Method Type, 2017-2021

    5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Method Type, 2022-2032

        5.3.1. Surgical Treatment

            5.3.1.1. Mechanical Debridement

            5.3.1.2. Laser Debridement

            5.3.1.3. Open Flap Debridement

            5.3.1.4. Open Flap Debridement with guided bone generation

        5.3.2. Non-Surgical Treatment

            5.3.2.1. Surface Debridement

            5.3.2.2. Antibiotics ( Chlorhexidine Digluconate )

            5.3.2.3. Others

    5.4. Y-o-Y Growth Trend Analysis By Method Type, 2017-2021

    5.5. Absolute $ Opportunity Analysis By Method Type, 2022-2032

6. Global Peri-implantitis Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By End User

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Mn) Analysis By End User, 2017-2021

    6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End User, 2022-2032

        6.3.1. Hospitals

        6.3.2. Dental Clinics

    6.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021

    6.5. Absolute $ Opportunity Analysis By End User, 2022-2032

7. Global Peri-implantitis Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Region

    7.1. Introduction

    7.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021

    7.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032

        7.3.1. North America

        7.3.2. Latin America

        7.3.3. Europe

        7.3.4. Asia Pacific

        7.3.5. MEA

    7.4. Market Attractiveness Analysis By Region

8. North America Peri-implantitis Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        8.2.1. By Country

            8.2.1.1. U.S.

            8.2.1.2. Canada

        8.2.2. By Method Type

        8.2.3. By End User

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Method Type

        8.3.3. By End User

    8.4. Key Takeaways

9. Latin America Peri-implantitis Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        9.2.1. By Country

            9.2.1.1. Brazil

            9.2.1.2. Mexico

            9.2.1.3. Rest of Latin America

        9.2.2. By Method Type

        9.2.3. By End User

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Method Type

        9.3.3. By End User

    9.4. Key Takeaways

10. Europe Peri-implantitis Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        10.2.1. By Country

            10.2.1.1. Germany

            10.2.1.2. U.K.

            10.2.1.3. France

            10.2.1.4. Spain

            10.2.1.5. Italy

            10.2.1.6. Rest of Europe

        10.2.2. By Method Type

        10.2.3. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Method Type

        10.3.3. By End User

    10.4. Key Takeaways

11. Asia Pacific Peri-implantitis Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        11.2.1. By Country

            11.2.1.1. China

            11.2.1.2. Japan

            11.2.1.3. South Korea

            11.2.1.4. Malaysia

            11.2.1.5. Singapore

            11.2.1.6. Australia

            11.2.1.7. Rest of Asia Pacific

        11.2.2. By Method Type

        11.2.3. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Method Type

        11.3.3. By End User

    11.4. Key Takeaways

12. MEA Peri-implantitis Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        12.2.1. By Country

            12.2.1.1. GCC Countries

            12.2.1.2. South Africa

            12.2.1.3. Israel

            12.2.1.4. Rest of MEA

        12.2.2. By Method Type

        12.2.3. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Method Type

        12.3.3. By End User

    12.4. Key Takeaways

13. Key Countries Peri-implantitis Treatment Market Analysis

    13.1. U.S.

        13.1.1. Pricing Analysis

        13.1.2. Market Share Analysis, 2021

            13.1.2.1. By Method Type

            13.1.2.2. By End User

    13.2. Canada

        13.2.1. Pricing Analysis

        13.2.2. Market Share Analysis, 2021

            13.2.2.1. By Method Type

            13.2.2.2. By End User

    13.3. Brazil

        13.3.1. Pricing Analysis

        13.3.2. Market Share Analysis, 2021

            13.3.2.1. By Method Type

            13.3.2.2. By End User

    13.4. Mexico

        13.4.1. Pricing Analysis

        13.4.2. Market Share Analysis, 2021

            13.4.2.1. By Method Type

            13.4.2.2. By End User

    13.5. Rest of Latin America

        13.5.1. Pricing Analysis

        13.5.2. Market Share Analysis, 2021

            13.5.2.1. By Method Type

            13.5.2.2. By End User

    13.6. Germany

        13.6.1. Pricing Analysis

        13.6.2. Market Share Analysis, 2021

            13.6.2.1. By Method Type

            13.6.2.2. By End User

    13.7. U.K.

        13.7.1. Pricing Analysis

        13.7.2. Market Share Analysis, 2021

            13.7.2.1. By Method Type

            13.7.2.2. By End User

    13.8. France

        13.8.1. Pricing Analysis

        13.8.2. Market Share Analysis, 2021

            13.8.2.1. By Method Type

            13.8.2.2. By End User

    13.9. Spain

        13.9.1. Pricing Analysis

        13.9.2. Market Share Analysis, 2021

            13.9.2.1. By Method Type

            13.9.2.2. By End User

    13.10. Italy

        13.10.1. Pricing Analysis

        13.10.2. Market Share Analysis, 2021

            13.10.2.1. By Method Type

            13.10.2.2. By End User

    13.11. Rest of Europe

        13.11.1. Pricing Analysis

        13.11.2. Market Share Analysis, 2021

            13.11.2.1. By Method Type

            13.11.2.2. By End User

    13.12. China

        13.12.1. Pricing Analysis

        13.12.2. Market Share Analysis, 2021

            13.12.2.1. By Method Type

            13.12.2.2. By End User

    13.13. Japan

        13.13.1. Pricing Analysis

        13.13.2. Market Share Analysis, 2021

            13.13.2.1. By Method Type

            13.13.2.2. By End User

    13.14. South Korea

        13.14.1. Pricing Analysis

        13.14.2. Market Share Analysis, 2021

            13.14.2.1. By Method Type

            13.14.2.2. By End User

    13.15. Malaysia

        13.15.1. Pricing Analysis

        13.15.2. Market Share Analysis, 2021

            13.15.2.1. By Method Type

            13.15.2.2. By End User

    13.16. Singapore

        13.16.1. Pricing Analysis

        13.16.2. Market Share Analysis, 2021

            13.16.2.1. By Method Type

            13.16.2.2. By End User

    13.17. Australia

        13.17.1. Pricing Analysis

        13.17.2. Market Share Analysis, 2021

            13.17.2.1. By Method Type

            13.17.2.2. By End User

    13.18. Rest of Asia Pacific

        13.18.1. Pricing Analysis

        13.18.2. Market Share Analysis, 2021

            13.18.2.1. By Method Type

            13.18.2.2. By End User

    13.19. GCC Countries

        13.19.1. Pricing Analysis

        13.19.2. Market Share Analysis, 2021

            13.19.2.1. By Method Type

            13.19.2.2. By End User

    13.20. South Africa

        13.20.1. Pricing Analysis

        13.20.2. Market Share Analysis, 2021

            13.20.2.1. By Method Type

            13.20.2.2. By End User

    13.21. Israel

        13.21.1. Pricing Analysis

        13.21.2. Market Share Analysis, 2021

            13.21.2.1. By Method Type

            13.21.2.2. By End User

    13.22. Rest of MEA

        13.22.1. Pricing Analysis

        13.22.2. Market Share Analysis, 2021

            13.22.2.1. By Method Type

            13.22.2.2. By End User

14. Market Structure Analysis

    14.1. Competition Dashboard

    14.2. Competition Benchmarking

    14.3. Market Share Analysis of Top Players

        14.3.1. By Regional

        14.3.2. By Method Type

        14.3.3. By End User

15. Competition Analysis

    15.1. Competition Deep Dive

        15.1.1. Pfizer Inc.

            15.1.1.1. Overview

            15.1.1.2. Product Portfolio

            15.1.1.3. Profitability by Market Segments

            15.1.1.4. Sales Footprint

            15.1.1.5. Strategy Overview

                15.1.1.5.1. Marketing Strategy

        15.1.2. Cadila Pharmaceuticals

            15.1.2.1. Overview

            15.1.2.2. Product Portfolio

            15.1.2.3. Profitability by Market Segments

            15.1.2.4. Sales Footprint

            15.1.2.5. Strategy Overview

                15.1.2.5.1. Marketing Strategy

        15.1.3. R.N. Laboratories Pvt. Ltd.

            15.1.3.1. Overview

            15.1.3.2. Product Portfolio

            15.1.3.3. Profitability by Market Segments

            15.1.3.4. Sales Footprint

            15.1.3.5. Strategy Overview

                15.1.3.5.1. Marketing Strategy

        15.1.4. Basic Pharma Life Science Pvt. Ltd.

            15.1.4.1. Overview

            15.1.4.2. Product Portfolio

            15.1.4.3. Profitability by Market Segments

            15.1.4.4. Sales Footprint

            15.1.4.5. Strategy Overview

                15.1.4.5.1. Marketing Strategy

        15.1.5. Prachi Pharmaceuticals Private Limited.

            15.1.5.1. Overview

            15.1.5.2. Product Portfolio

            15.1.5.3. Profitability by Market Segments

            15.1.5.4. Sales Footprint

            15.1.5.5. Strategy Overview

                15.1.5.5.1. Marketing Strategy

        15.1.6. Healthy Life Pharma Private Limited

            15.1.6.1. Overview

            15.1.6.2. Product Portfolio

            15.1.6.3. Profitability by Market Segments

            15.1.6.4. Sales Footprint

            15.1.6.5. Strategy Overview

                15.1.6.5.1. Marketing Strategy

        15.1.7. Triveni Chemicals

            15.1.7.1. Overview

            15.1.7.2. Product Portfolio

            15.1.7.3. Profitability by Market Segments

            15.1.7.4. Sales Footprint

            15.1.7.5. Strategy Overview

                15.1.7.5.1. Marketing Strategy

16. Assumptions & Acronyms Used

17. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Peri-implantitis Treatment Market Value (US$ Mn) Forecast by Region, 2017-2032

Table 2: Global Peri-implantitis Treatment Market Value (US$ Mn) Forecast by Method Type, 2017-2032

Table 3: Global Peri-implantitis Treatment Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 4: North America Peri-implantitis Treatment Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 5: North America Peri-implantitis Treatment Market Value (US$ Mn) Forecast by Method Type, 2017-2032

Table 6: North America Peri-implantitis Treatment Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 7: Latin America Peri-implantitis Treatment Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 8: Latin America Peri-implantitis Treatment Market Value (US$ Mn) Forecast by Method Type, 2017-2032

Table 9: Latin America Peri-implantitis Treatment Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 10: Europe Peri-implantitis Treatment Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 11: Europe Peri-implantitis Treatment Market Value (US$ Mn) Forecast by Method Type, 2017-2032

Table 12: Europe Peri-implantitis Treatment Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 13: Asia Pacific Peri-implantitis Treatment Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 14: Asia Pacific Peri-implantitis Treatment Market Value (US$ Mn) Forecast by Method Type, 2017-2032

Table 15: Asia Pacific Peri-implantitis Treatment Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 16: MEA Peri-implantitis Treatment Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 17: MEA Peri-implantitis Treatment Market Value (US$ Mn) Forecast by Method Type, 2017-2032

Table 18: MEA Peri-implantitis Treatment Market Value (US$ Mn) Forecast by End User, 2017-2032

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts

Figure 1: Global Peri-implantitis Treatment Market Value (US$ Mn) by Method Type, 2022-2032

Figure 2: Global Peri-implantitis Treatment Market Value (US$ Mn) by End User, 2022-2032

Figure 3: Global Peri-implantitis Treatment Market Value (US$ Mn) by Region, 2022-2032

Figure 4: Global Peri-implantitis Treatment Market Value (US$ Mn) Analysis by Region, 2017-2032

Figure 5: Global Peri-implantitis Treatment Market Value Share (%) and BPS Analysis by Region, 2022-2032

Figure 6: Global Peri-implantitis Treatment Market Y-o-Y Growth (%) Projections by Region, 2022-2032

Figure 7: Global Peri-implantitis Treatment Market Value (US$ Mn) Analysis by Method Type, 2017-2032

Figure 8: Global Peri-implantitis Treatment Market Value Share (%) and BPS Analysis by Method Type, 2022-2032

Figure 9: Global Peri-implantitis Treatment Market Y-o-Y Growth (%) Projections by Method Type, 2022-2032

Figure 10: Global Peri-implantitis Treatment Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 11: Global Peri-implantitis Treatment Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 12: Global Peri-implantitis Treatment Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 13: Global Peri-implantitis Treatment Market Attractiveness by Method Type, 2022-2032

Figure 14: Global Peri-implantitis Treatment Market Attractiveness by End User, 2022-2032

Figure 15: Global Peri-implantitis Treatment Market Attractiveness by Region, 2022-2032

Figure 16: North America Peri-implantitis Treatment Market Value (US$ Mn) by Method Type, 2022-2032

Figure 17: North America Peri-implantitis Treatment Market Value (US$ Mn) by End User, 2022-2032

Figure 18: North America Peri-implantitis Treatment Market Value (US$ Mn) by Country, 2022-2032

Figure 19: North America Peri-implantitis Treatment Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 20: North America Peri-implantitis Treatment Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 21: North America Peri-implantitis Treatment Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 22: North America Peri-implantitis Treatment Market Value (US$ Mn) Analysis by Method Type, 2017-2032

Figure 23: North America Peri-implantitis Treatment Market Value Share (%) and BPS Analysis by Method Type, 2022-2032

Figure 24: North America Peri-implantitis Treatment Market Y-o-Y Growth (%) Projections by Method Type, 2022-2032

Figure 25: North America Peri-implantitis Treatment Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 26: North America Peri-implantitis Treatment Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 27: North America Peri-implantitis Treatment Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 28: North America Peri-implantitis Treatment Market Attractiveness by Method Type, 2022-2032

Figure 29: North America Peri-implantitis Treatment Market Attractiveness by End User, 2022-2032

Figure 30: North America Peri-implantitis Treatment Market Attractiveness by Country, 2022-2032

Figure 31: Latin America Peri-implantitis Treatment Market Value (US$ Mn) by Method Type, 2022-2032

Figure 32: Latin America Peri-implantitis Treatment Market Value (US$ Mn) by End User, 2022-2032

Figure 33: Latin America Peri-implantitis Treatment Market Value (US$ Mn) by Country, 2022-2032

Figure 34: Latin America Peri-implantitis Treatment Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 35: Latin America Peri-implantitis Treatment Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 36: Latin America Peri-implantitis Treatment Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 37: Latin America Peri-implantitis Treatment Market Value (US$ Mn) Analysis by Method Type, 2017-2032

Figure 38: Latin America Peri-implantitis Treatment Market Value Share (%) and BPS Analysis by Method Type, 2022-2032

Figure 39: Latin America Peri-implantitis Treatment Market Y-o-Y Growth (%) Projections by Method Type, 2022-2032

Figure 40: Latin America Peri-implantitis Treatment Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 41: Latin America Peri-implantitis Treatment Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 42: Latin America Peri-implantitis Treatment Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 43: Latin America Peri-implantitis Treatment Market Attractiveness by Method Type, 2022-2032

Figure 44: Latin America Peri-implantitis Treatment Market Attractiveness by End User, 2022-2032

Figure 45: Latin America Peri-implantitis Treatment Market Attractiveness by Country, 2022-2032

Figure 46: Europe Peri-implantitis Treatment Market Value (US$ Mn) by Method Type, 2022-2032

Figure 47: Europe Peri-implantitis Treatment Market Value (US$ Mn) by End User, 2022-2032

Figure 48: Europe Peri-implantitis Treatment Market Value (US$ Mn) by Country, 2022-2032

Figure 49: Europe Peri-implantitis Treatment Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 50: Europe Peri-implantitis Treatment Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 51: Europe Peri-implantitis Treatment Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 52: Europe Peri-implantitis Treatment Market Value (US$ Mn) Analysis by Method Type, 2017-2032

Figure 53: Europe Peri-implantitis Treatment Market Value Share (%) and BPS Analysis by Method Type, 2022-2032

Figure 54: Europe Peri-implantitis Treatment Market Y-o-Y Growth (%) Projections by Method Type, 2022-2032

Figure 55: Europe Peri-implantitis Treatment Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 56: Europe Peri-implantitis Treatment Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 57: Europe Peri-implantitis Treatment Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 58: Europe Peri-implantitis Treatment Market Attractiveness by Method Type, 2022-2032

Figure 59: Europe Peri-implantitis Treatment Market Attractiveness by End User, 2022-2032

Figure 60: Europe Peri-implantitis Treatment Market Attractiveness by Country, 2022-2032

Figure 61: Asia Pacific Peri-implantitis Treatment Market Value (US$ Mn) by Method Type, 2022-2032

Figure 62: Asia Pacific Peri-implantitis Treatment Market Value (US$ Mn) by End User, 2022-2032

Figure 63: Asia Pacific Peri-implantitis Treatment Market Value (US$ Mn) by Country, 2022-2032

Figure 64: Asia Pacific Peri-implantitis Treatment Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 65: Asia Pacific Peri-implantitis Treatment Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 66: Asia Pacific Peri-implantitis Treatment Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 67: Asia Pacific Peri-implantitis Treatment Market Value (US$ Mn) Analysis by Method Type, 2017-2032

Figure 68: Asia Pacific Peri-implantitis Treatment Market Value Share (%) and BPS Analysis by Method Type, 2022-2032

Figure 69: Asia Pacific Peri-implantitis Treatment Market Y-o-Y Growth (%) Projections by Method Type, 2022-2032

Figure 70: Asia Pacific Peri-implantitis Treatment Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 71: Asia Pacific Peri-implantitis Treatment Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 72: Asia Pacific Peri-implantitis Treatment Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 73: Asia Pacific Peri-implantitis Treatment Market Attractiveness by Method Type, 2022-2032

Figure 74: Asia Pacific Peri-implantitis Treatment Market Attractiveness by End User, 2022-2032

Figure 75: Asia Pacific Peri-implantitis Treatment Market Attractiveness by Country, 2022-2032

Figure 76: MEA Peri-implantitis Treatment Market Value (US$ Mn) by Method Type, 2022-2032

Figure 77: MEA Peri-implantitis Treatment Market Value (US$ Mn) by End User, 2022-2032

Figure 78: MEA Peri-implantitis Treatment Market Value (US$ Mn) by Country, 2022-2032

Figure 79: MEA Peri-implantitis Treatment Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 80: MEA Peri-implantitis Treatment Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 81: MEA Peri-implantitis Treatment Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 82: MEA Peri-implantitis Treatment Market Value (US$ Mn) Analysis by Method Type, 2017-2032

Figure 83: MEA Peri-implantitis Treatment Market Value Share (%) and BPS Analysis by Method Type, 2022-2032

Figure 84: MEA Peri-implantitis Treatment Market Y-o-Y Growth (%) Projections by Method Type, 2022-2032

Figure 85: MEA Peri-implantitis Treatment Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 86: MEA Peri-implantitis Treatment Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 87: MEA Peri-implantitis Treatment Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 88: MEA Peri-implantitis Treatment Market Attractiveness by Method Type, 2022-2032

Figure 89: MEA Peri-implantitis Treatment Market Attractiveness by End User, 2022-2032

Figure 90: MEA Peri-implantitis Treatment Market Attractiveness by Country, 2022-2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Inflammatory Markers Market

Published : August 2019

Healthcare

Pelvic Inflammatory Disease Therapeutics Market

Published : June 2018

Healthcare

Rare Inflammatory Disease Treatment Market

Published : December 2021

Healthcare

Inflammatory Diseases Market

Published : January 2017

Google translate

Peri-implantitis Treatment Market